Brendan Flanagan
About Brendan Flanagan
Brendan Flanagan is a Principal Research Associate specializing in Tissue Culture at Alloy Therapeutics, Inc., where he supports human antibody discovery efforts. He holds a Bachelor's degree in Biology from Saint Michael's College and has accumulated diverse experience in research and quality assurance roles across several organizations.
Work at Alloy Therapeutics
Brendan Flanagan currently holds the position of Principal Research Associate in Tissue Culture at Alloy Therapeutics, Inc. since 2021. In this role, he supports in vivo human antibody discovery efforts utilizing the Alloy-Gx Mouse platform. His responsibilities include evaluating immune titers through ELISA and flow cytometry techniques, as well as performing flow cytometric characterization of mammalian research cell lines.
Previous Experience in Research and Quality Assurance
Prior to his current role, Brendan Flanagan worked at several organizations in various capacities. He served as a Research Associate at Olaris, Inc. for four months in 2020, and as a College Laboratory Researcher at Saint Michael's College for 11 months in 2017. Additionally, he gained experience as a Quality Assurance Intern at Cabot Creamery Co-operative for three months in 2017, and as an Associate ELISA Scientist at Green Mountain Antibodies from 2018 to 2020.
Education and Expertise
Brendan Flanagan earned a Bachelor's degree in Biology from Saint Michael's College, where he studied from 2014 to 2018. His academic background provides a foundation for his expertise in tissue culture, hybridoma generation, and antibody characterization. His education has equipped him with the necessary skills to perform complex laboratory techniques and contribute to research initiatives.
Research Contributions and Techniques
In his research roles, Brendan Flanagan has generated hybridomas through fusions and collected hybridoma supernatants. He has cultured and maintained mammalian research cell lines, optimizing growth media for improved results. His work includes screening hybridomas and characterizing antibodies using various binding and functional assays, demonstrating his proficiency in laboratory techniques essential for antibody discovery.